MMR Vaccine Sales Boost Merck’s 2019 Revenues

MMR Vaccine Sales Boost Merck’s 2019 Revenues

After the Centers for Disease Control and Prevention (CDC) publicized measles outbreaks in several states beginning in January 2019, on May 1 Merck & Co. announced that it had increased production of its live attenuated (weakened) virus MMR (measles, mumps, rubella) vaccine in response to an increasing demand for the product in the United States. As of July 25, there have been 1,164 confirmed cases of measles in 30 states and there have been similar large increases in reported measles cases in other countries this year.1 2 3 4

“As measles outbreaks have occurred in different parts of the world over the last few decades, we’ve always been able to surge capacity, and we feel confident about our ability to do so in the U.S.” said Merck Chief Marketing Officer Mark Nally.1

On July 30, Merck reported that sales of its vaccines for children rose by 58 percent during the second quarter of this year to $675 million, compared to the second quarter of 2018. The company acknowledged that the spike in sales was boosted by sales of its MMR vaccine.5

Merck Chief Commercial Officer Frank Clyburn notes, “There was some buying to the private sector within the U.S. this quarter based on some of the measles outbreaks that you read in the news. And we do believe that we’ll continue to see growth for our pediatric vaccines going forward.”5

Merck is the sole supplier of measles vaccines in the U.S.1 5 It produces two measles vaccines, including the MMR II and ProQuad, which is a combination measles, mumps, rubella, and varicella (MMRV) vaccine.6

The CDC recommends that children receive two doses of MMR vaccine—the first dose at 12-15 months of age and the second dose at 4-6 six years. Additionally, according to the National Vaccine Information Center (NVIC), “CDC recommendations state that persons age 18 or older, who were born in 1957 or later, should get at least one dose of MMR if there is no laboratory evidence of naturally acquired measles immunity or documentation that a measles vaccine was given on or after the first birthday.”7

There are several other manufacturers of MMR vaccines in the world, including AstraZeneca and GlaxoSmithKline of the United Kingdom, Sanofi Pasteur of France and Serum Institute of India, but Merck is the only company licensed to sell a measles containing vaccine in the U.S.8


References:

6 Responses to "MMR Vaccine Sales Boost Merck’s 2019 Revenues"

  1. eevie   August 2, 2019 at 11:09 am

    Measles is coming thru our borders by illegals. It is part of the elitist agenda and it is then spread by the ones who are vaccinated. Several years ago I came down with whooping cough from vaccinated children.

    Reply
    • Redpill   August 2, 2019 at 8:14 pm

      “Measles is coming thru our borders by illegals.”

      I suppose you have hard scientific data to substantiate that claim. Please post it.

      Measles is a illness that occurs in cycles every 2-3 years. Look at the documented history. You have years where the number of outbreaks is high followed by years where outbreaks are low.

      Measles comes and goes irrespective of vaccination

      Childhood diseases run in cycles no matter what the vaccination rates:
      Every 2-3 years, there is an upsurge of measles irrespective of vaccination compliance.
      Robertson SE, Markowitz LE, Dini EF, Orenstein WA. 1992. A million-dollar measles outbreak: epidemiology, risk factors, and selective revaccination strategy. Publ Health Reports. 1992;197(1):24-31. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1403597/

      It’s all about Mother Nature and the attempted distortion of it.

      Reply
  2. TJB 323   August 2, 2019 at 12:14 pm

    How convenient for Merck that this outbreak happened. How convenient that they are the only company to profit from the mass frenzy of a wopping 1100 some folks out of over 300 million people in the US who got measles. How convenient that they alone can “SAVE US ALLLLLLLL”. (Not) How convenient that if any harm befalls any child or adult from there vaccine Merck suffers no consequences what so ever.

    Reply
  3. Shannon   August 2, 2019 at 3:32 pm

    The measle outbreaks we see are not the “wild” measles that children would normally get but rather a modified measles strain used in vaccines (MMR vaccine). It is vaccinated children that are causing the measle outbreaks, a sort of false flag, that increases sales of the MMR vaccine and thus increasing profits.

    Reply
  4. Redpill   August 2, 2019 at 8:16 pm

    Merck’s Sales Soar on Measles Vaccine After Disney Outbreak
    https://vaccineimpact.com/2015/mercks-sales-soar-on-measles-vaccine-after-disney-outbreak/

    Why is anyone surprised.

    Reply
  5. DN   August 4, 2019 at 12:23 pm

    Whopping cough vaccine only 40% effective same with flu.

    Reply

Leave a Reply to eevie Cancel Reply

Your email address will not be published.